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Summary.-The chronic administration of N-2-acetylaminofluorene (N-2-AAF) to
rats causes a loss of hepatic cytoplasmic RNA, particularly from the endoplasmic-
membrane fractions. At the end of the complete carcinogenic dose, the level of amino-
acid incorporation into proalbumin is normal, despite the loss of 35%0 of membrane-
bound RNA. The secretion of albumin, however, is inhibited. This inhibition of
secretion is apparently the result of a change in membrane flow and differentiation;
transfer of nascent protein from smooth-surfaced vesicles to the Golgi apparatus is
blocked. The significance of these findings is discussed.
CHRONIC ADMINISTRATION of a number
of chemically diverse carcinogens has been
shown to decrease the amount of hepatic
rough endoplasmic reticulum in vivo
(Flaks, 1970; Porter & Bruni, 1959;
Williams et al., 1973; Svoboda & Higgin-
son, 1968; Farber, 1956) either by morpho-
logical analysis (e.g. after N-2-acetyl-
aminofluorine (N-2-AAF), 3'methyldi-
methylaminoazobenzene, ethionine orthio-
acetamide) or by subeellular fractionation
and chemical analysis (in the case of
aflaxtoxin B1). The loss of hepatic rough
endoplasmic reticulum is the single com-
mon change caused by the carcinogens
studied, except for proliferation of smooth
endoplasmic reticulum which is a normal
response to xenobiotic treatment.
Membrane-bound ribosomes are con-
sidered responsible for the synthesis of
proteins destined for both intracellular use
and for secretion (Tanaka & Ogata, 1972;
Rolleston, 1974), whilst free ribosomes are
thought to be the site ofsynthesis ofintra-
cellular proteins only (Redman, 1969;
Ragnotti et al., 1970). A change in the dis-
tribution of free and membrane-bound
ribosomes will therefore change the pat-
tern of synthesis and intracellular trans-
location ofsome nascent proteins. The aim
of this study was to define the changes in
the subcellular distribution of ribosomes
and in the accompanying patterns of pro-
tein synthesis, during chronic carcinogen
treatment.
N-2-acetylaminofluorene (N-2-AAF) has
been much studied, and its effects on
tissue morphology and function are rela-
tively well characterized. It was therefore
chosen as the carcinogen for the present
study. N-2-AAF has been shown to reduce
the number of membrane-bound ribo-
somes in vivo (Flaks, 1970) and in vitro
(Palmer et al., 1978), whilst the non-
carcinogenic N-4-AAF has no effect in vivo
(Flaks, 1972) or in vitro (Williams & Parry,
1975). N-2-AAF is also a carcinogen of
relatively low toxicity which causes no
detectable gross damage to the nucleolus
or the nucleus when administered in a
carcinogenic dose (Flaks, 1970) and,
finally, a minimum period of exposure to
the carcinogen (4 weeks for this regimen
of treatment) is needed to initiate an
irreversible progression towards neoplasia
which takes 5-8 months (Miller et al.,
1961). Changes in ribosome number, and
in the synthesis and translocation of pro-
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teins, may be of importance in the stage
of carcinogenesis which is dependent on
the continued presence of the carcinogen.
This paper describes the progressive loss
of membrane-bound ribosomes, and the
accompanying disruption in hepatic pro-
tein secretion, during N-2-AAF adminis-
tration.
MATERIALS AND METHODS
Chemicals.-N-2-Acetylaminofluorine was
obtained from Koch-Light Laboratories Ltd,
DEAE cellulose DE 52 was supplied by
Whatman Inc., New Jersey, and Gum
Arabic was supplied by B.D.H. Chemicals
Ltd. Soluene was supplied by Packard Inc.,
Illinois. Rabbit anti-rat serum albumin was
obtained from Uniscience, Cambridge.
RNase-free sucrose was supplied by Fison's
Scientific Apparatus and used throughout.
L-{4,5[3H]leucine} 40,000-60,000 mCi/mmol
and L-{U[14C]leucine}>270 mCi/mmol were
supplied by the Radiochemical Centre,
Amersham. All other chemicals were of
analytical reagent grade.
Carcinogen administration.-Male Sprague-
Dawley rats, initially weighing 195-205 g, fed
Dixon's B41 (Ware, England) diet ad libitum,
were treated 3 times a week for 4 weeks.
Control rats received 1 ml 7% Gum Arabic in
isotonic saline i.p. each week, whilst treated
rats received 10 mg N-2-AAF per week i.p. in
addition (Miller et al., 1961). Animals were
killed by cervical dislocation 64 h after the
last injection.
Cell fractionation.-Total microsomes were
prepared by flotation, using the method of
Palmer et al. (1978). Heavy rough endo-
plasmic reticulum was isolated according to
the method of Parry (1975) using a homo-
genization medium containing 0-35M sucrose,
2-5mM magnesium acetate. Livers perfused
with ice-cold saline were homogenized in 2-5
vol medium at 1000 revs/min for 1 min in a
Potter-Elvehjem homogenizer of 0-010 inch
clearance and filtered through 2 layers of
bolting cloth. The homogenate was centri-
fuged for 10 min at 650 g in a bench centri-
fuge. The pellet was resuspended in 4 vol of
homogenization medium and diluted with
water to give a final sucrose concentration of
0-27 M. 26 ml was layered over 8 ml of
homogenizing medium and centrifuged at
360 g for 10 min in a bench centrifuge. The
entire supernatant was recovered and spun
at 10,000 g for 10 min. The pellet was re-
suspended in homogenizing medium.
"Total bound RNA" refers to the total
RNA recovered from microsomal and heavy
rough endoplasmic reticulum (RER) fractions.
Rough and smooth microsomal membrane
fractions were prepared by the method of
Williams et al. (1969).
Fractions enriched in smooth microsomes
and Golgi apparatus were prepared by a
modification of the method of Fleischer &
Fleischer (1970). The homogenization medium
contained 0-5M sucrose and 0-IM Na2HPO4/
NaH2PO4 buffer, pH 7-1. After centriguation
for 10 min at 750 g in a bench centrifuge,
7-5 ml supernatant was layered on to a dis-
continuous sucrose gradient consisting of
8 ml each of sucrose solutions ofdensity 1-12,
1.14, 1.16 and 1.18 in Na2HPO4/NaH2PO4
buffer, pH 7-1. After centrifugation for 1 h
at 85,000 g in a Beckman 30 rotor, the Golgi-
enriched fraction was collected from the
layers of density 1-12-1-14. The smooth
microsome fraction was collected from the
interface of the 1-16 and 1-18 layers. Both
fractions were pelleted and washed twice.
The specific activity of UDP-galactose-N-
acetylglucosamine galactosyl transferase of
homogenate was 2-29 nmol galactose/h. The
specific activity of the smooth microsome-
enriched-fraction was 4-03 nmol galactose/h,
1-71 x that of homogenate, and the specific
activity of the Golgi enriched fraction was
391 nmol galactose/h, 171 times that of
homogenate. The smooth-microsome fraction
contained 31% of homogenate activity, and
the Golgi fraction contained 81% of homo-
genate activity.
Chemical and enzymic estimations.-Protein
was estimated by the method of Lowry and
RNA by the method of Schmidt & Thann-
hauser (1945), using the extinction coefficient
for RNA quoted by Fleck & Begg (1965).
UDP-galactose-N-acetylglucosamine galacto-
syl transferase was assayed according to
Fleischer et al. (1969), with an incubation
time of 15 min. In all enzyme assays, doub-
ling enzyme concentration doubled measured
activity.
In vitro protein synthesis.-The inorganic-
ion concentration of incubation media was
that described by Krebs & Henselheit (1932),
while the glucose and amino-acid concentra-
tion was that of Greene et al. (1931). Four
slices, weighing 0-03 g each (surface area
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-0-25 mm2) were preincubated for 6 min at
37°C before addition of 0-5 ,uCi U-14C-
{L-leucine}. After 60 min, incorporation was
stopped by removing the slices into ice-cold
0-25M STKME containing 3mM cyclohexi-
mide. Incorporation of radioactivity into
homogenate increased linearly with time for
at least 60 min. Samples for scintillation
counting were precipitated on Millipore
GF/C filters by adding 1 vol 10% ice-cold
trichloroacetic acid, containg 8mM leucine,
and washed x 3 with 10 ml 5% trichloro-
acetic acid containing 8mM leucine.
Albumin and proalbumin purification.-
Albumin was putified from serum by the
method ofDebro et at. (1957) followed by ion-
exchange chromatography (Dorling et al.,
1975). 3H-carrier albumin was prepared by
the same procedure, after incorporation of
lmCi L-4,5[3H]leucine per rat for 70 min.
Routinely the sp. act. was 25,000-30,000
ct/min/mg. Estimation of intracellular albu-
min and proalbumin involved isotopic dilu-
tion with 3H-carrier albumin, followed by
purification by precipitation with anti-rat
serum albumin and ion-exchange chromato-
graphy (Dorling et al., 1975). Precipitation of
samples for scintillation counting was carried
out as below.
Scintillation counting.-Samples were
solubilized using Soluene-350 in 10ml toluene
containing 0-5% w/v 2,5-diphenyloxazole and
0-025% w/v 1,4-di (2-(4-methyl-5-phenyl-
oxazolyl) benzene.
RESULTS
The data presented in Table I show that
the RNA content of hepatic postmito-
chondrial supernatant from N-2-AAF-
treated animals is lower than that of con-
trol rats throughout treatment. Control
rats show an age-dependent decrease in
the content of both free and membrane-
bound RNA. The amount of total mem-
brane-bound RNA (as defined in Materials
and Methods) is also reduced during car-
cinogen treatment. After 1 week of treat-
ment, total extranuclear RNA is decreased
by 35% (P < 0-02) and membrane-bound
RNA by 28% (P<0-1), whilst after 2
weeks there is 10% less extranuclear RNA
(P < 0-05) and 17% less membrane-bound
RNA (P < 0-2) in treated than in control
rats. After 4 weeks of treatment, the level
of extranuclear RNA is still 10% lower
than in control animals (P < 0-02) but the
content of membrane-bound RNA is now
35% lower than in control rat liver
(P< 0-01). Throughout N-2-AAF treat-
ment there is no significant difference in
the pattern of changes of RNA content of
total microsomes and heavy rough endo-
plasmic reticulum, confirming that the
measured loss of RNA from endoplasmic
membranes is not an artefact of micro-
somal-membrane fractionation.
Having established a change in both the
number and subcellular distribution of
ribosomes, liver slices were used for an
initial survey of amino-acid incorporation
into subcellular fractions. After 1, 2 and 4
weeks of carcinogen administration, there
was no statistically significant difference
between amino-acid incorporation into
homogenate of slices from normal and
treated animals. The only major change
in incorporation was into the incubation
medium, i.e. into putative secretory pro-
tein. The proportion of total acid-pre-
cipitable incorporation appearing in the
medium was 0-27 + 0-02, in slices from
control animals at all times. After 2 weeks
of treatment, however, in slices from
treated animals, it was 0-14 + 0-04 and
after 4 weeks it was 0-06 + 0-02.
The major secretory protein of liver is
serum albumin which is known to be made
only by membrane-bound ribosomes
(Tanaka & Ogata, 1972). No change was
found in the circulating-albumin level of
treated rats until the end of treatment,
when the concentration was 43% that of
control rats (Table II) P< 0-01. Incor-
poration of radio-labelled amino acid 1 h
after i.p. injection (when most ofthe label
has passed through the liver) into plasma
albumin is dramatically reduced to 31%
of the control level at this stage of treat-
ment (P< 0-02). The results presented in
Table III, however, show that after 4
weeks of treatment the incorporation of
leucine into proalbumin in the rough
microsomes of treated and control rats is
identical per g liver. Incorporation ofM. M. HARSON AND D. J. WILLIAMS
TABLE I.-RNA content of liversfrom normal and N-2-AFF-treated rats
A Total extranuclear RNA
(mg/g liver)
Control
Treated
Treated/Control
B Total membrane-bound*
RNA (mg/g liver)
Control
Treated
Treated/Control
B/A
Control
Treated
Treated/Control
Weeks of treatment
r I
1 2 4
8-1+ 0-2 7-0+ 0-16 6-6+ 0-15
5-2+0-13 6-35+0-15 5-85+0-14
0-64+0-025 0-91+0-03 0-89+0-03
5-26+ 0-18
3-84+ 0-12
0-72 + 0-03
0-65 + 0-12
0-74+ 0-13
1-14 + 0-04
4-2+0-15
3-57+0-11
0-83 + 0-03
0-60+0-1
0-56+0-11
0-94+ 0-09
3-9 + 0-13
2-51 + 0-10
0-65 + 0-023
0-59+0-11
0-43 + 0-10
0-73 + 0-06
Values are shown +s.e. Each result is the average of 3 separate experiments,
each using a pool of 5 rats.
* Total membrane-bound RNA is defined in the Methods section.
TABLE II.-The concentration of and incorporation into plasma albumin of radio-labelled
amino acid in normal and N-2-AAF-treated rats
Weeks oftreatment
Concentration ofalbumin in
plasma (mg albumin/mlserum)
Control 29-3 +1-7
Treated 30-0 + 1-4
Treated/control 1-04 + 0-065
Incorporation into plasma
albumin (d/min/m/serum)
Control
Treated
Treated/control
2
28-4 + 1-6
30-0 + 1-8
1-04 + 0-060
4
26-0 + 1-3
11-1 +0-57
0-43 + 0-021
- 5270 + 250
2160 + 101
0-38 + 0-018
4 ,Ci L-U[14C]leucine per 100 g body wt was injected i.p. Incorporation into
plasma albumin was determined 60 min after injection. Values are shown + s.e.
and are the mean of 2 separate experiments, each using a pool of 5 rats.
TABLE III.-The incorporation of 14C-leucine into proalbumin and total proteins* in
rough-surfaced membranes of the livers from control rats and those after 4 weeks of
N-2-AFF administration
Control
Incorporation (d/min/g wet wt)
Proalbumin
Total proteins*
Incorporation (d/min/mg
microsomal RNA)
Proalbumin
Total proteins*
Treated Treated/control
2,610+ 120 2,430 + 90
52,200+ 3450 37,060+ 2500
669+ 39 972+ 32
13,385 ± 803 14,723 + 972
0-93 + 0-052
0-71 + 0-034
1-53 + 0-092
1-10+ 0-064
Rough-membrane-associated
proalbumin (,ug/g wet wt) 151 + 7 116 + 5 0-77 + 0-031
Incorporation of 4 ,tCi L-U[14C]leucine/100 g body wt 15 min after i.p. injec-
tion of labelled amino acid. Values are shown +s.e. and are the mean of 2
separate experiments, each using a pool of 5 rats.
* Total proteins are microsomal membrane+luminal+rough membrane-
associated nascent protein.
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TABLE IV.-Incorporation of 14C-leucine into and concentration of albumin and pro-
albumin in livers of rats treated for 4 weeks with N-2-AAF, and of control animals
Control
Smooth microsomes
Incorporation into proalbumin
(d/min/g wet wt) 1080 + 66
Concentration ofproalbumin
(Kg/g wetwt) 175+ 25
Golgi apparatus
Incorporation into proalbumin
+albumin (d/min/g
wet wt) 690 + 28
Concentration ofproalbumin
+albumin (pAg/g wet wt) 126+19
Post-nuclear supernatant
Concentration ofalbumin +
proalbumin (,g/g wet wt) 600 + 30
Treated Treated/control
2058+ 240 1-78 + 0-26
538 + 50 3*0 + 0-25
618+ 24 0*9 +0-075
52 + 6 0-41 + 0-008
820 + 39 1-37 + 0 054
Incorporation into these hepatic subfractions was determined 20 min after
injection i.p. of 4 ,uCi L-U[14C]leucine/100 g body wt. Values are shown +s.e.
and are the mean of 2 separate experiments, each using a pool of 5 rats.
leucine into total protein (i.e. membrane,
luminal and nascent proteins) of rough
microsomes per g liver in treated rats is
75% that of control incorporation. Bear-
ing in mind the loss of 35% ofmembrane-
bound RNA, incorporation into total pro-
teins is about the same, per mg RNA, in
treated and control animals, and the in-
corporation into proalbumin, per mg
RNA, in treated rats is 153% that of con-
trol rats (P< 0.01). Therefore, we conclude
that the ribosomes which are lost from the
endoplasmic reticulum are not those which
synthesize proalbumin.
Thus, despite the loss of membrane-
bound ribosomes throughout N-2-AAF
treatment, there is no change in the in-
corporation into proalbumin in rough
microsomes. However, after 4 weeks of
treatment the circulating albumin con-
centration is below normal. An exmina-
tion of the steady-state concentration of
proalbumin and albumin in hepatic mem-
brane subfractions (Table IV) explains
this apparent discrepancy. The level of
proalbumin in a smooth microsome frac-
tion (substantially free of Golgi mem-
brane) from treated rats is 3 times the
control level (P<0.02). In contrast, the
level of albumin and precursor in a Golgi
fraction from treated rats is 43% that of
controls (P< 0.02). These findings suggest
a block in the translocation ofproalbumin
from smooth microsomes to the Golgi
apparatus. That this block in the export
pathway occurs at the transition ofsmooth
microsomes to Golgi apparatus is sup-
ported by the identical change in concen-
tration of albumin in the Golgi apparatus
and the plasma. In order to account for
the loss of circulating plasma albumin, it
is necessary however to postulate that not
only does proalbumin accumulate in
smooth membranes, but also that this
smooth-membrane proalbumin is rapidly
degraded. The situation is analogous to
that ofthe selective autophagy ofinduced
smooth membranes in liver following
removal of the inducer (Bolender &
Weibel, 1973).
DISCUSSION
The experiments described above indi-
cate a significant change in the amount
and intracellular distribution of hepatic
cytoplasmic RNA during N-2-AAF ad-
ministration. Such changes are in accord
with the results of a morphological study
by Flaks (1970). Significantly, the loss of
membrane-bound ribosomes is caused by
chronic treatment with a wide range of
chemical carcinogens (Farber, 1956;
Porter & Bruni, 1959; Svoboda & Higgin-
son, 1968; Williams et al., 1973) and indeed
is the only common morphological change
795796 M. M. HARSON AND D. J. WILLIAMS
reported. Such changes are expected to
have dramatic effects on the pattern of
protein synthesis.
The data presented here, however,
strongly suggest that the synthesis of
proalbumin, the precursor of plasma
albumin, is unaffected by carcinogen
treatment, eventhough 35% ofmembrane-
bound ribosomes have been lost. Clearly
the lost polyribosomes are not responsible
for albumin biosynthesis. It would be of
great interest to identify the proteins lost
or mislocated during carcinogen-induced
degranulation, since this is likely to be a
common phenomenon in the early stages
of chemical carcinogenesis. Apart from the
synthesis of proteins for secretion, mem-
brane-bound polyribosomes are believed
to be involved in the synthesis of some
nuclear proteins, and ofmembrane protein
themselves (Shore & Tata, 1977).
The major effect reported here is the
inhibition of secretion that accompanies
membrane degranulation. It seems likely
that the loss of membrane-bound poly-
ribosomes may affect the synthesis and
insertionofnormalmembraneconstituents,
and lead eventually to the defective
assembly of other membranes. During
N-2-AAF treatment, albumin accumulates
in smooth-surfaced membranes originating
from the endoplasmic reticulum, and is
depleted in vesicles derived from the Golgi
apparatus, suggesting a block in the
normal transfer of nascent secretory pro-
tein from smooth endoplasmic reticulum
to Golgi apparatus before secretion. The
change in differentiation of smooth endo-
plasmic reticulum caused by N-2-AAF is
a long-term effect, in contrast to the
reversible short-term effect reported for
colchicine and fibrinogen. Colchicine causes
a decrease in secretion of albumin accom-
panied by an accumulation in the Golgi
apparatus (Dorling et al., 1975; Redman
et al., 1975), while fibrinogen causes a
decrease in secretion of albumin which is
accompanied by an accumulation initially
in the rough microsomes, but subsequently
in the Golgi apparatus (Feldmann et al.,
1975).
The effects of carcinogens on endo-
plasmic membrane function are therefore
far-reaching. Some proteins normally
made by membrane-bound polyribosomes
must be deleted or mislocated, although
proalbumin synthesis itself appears to be
unaffected. The defect in the membranous
secretory pathway, which may itself
reflect the defective assembly of endo-
plasmic membranes caused by degranu-
lation, will clearly have a dramatic effect
on intracellular compartmentation as well
as on the structures of other membranes
within and around the cell.
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